The effect of PPIs Alone, PPIs plus cytoprotective agent, and H2RA plus cytoprotective agent on ulcer healing after endoscopic submucosal dissection: A prospective randomized controlled trial
Arab Journal of Gastroenterology · 2021-06 · 22 (2) · 115-120
DOI: 10.1016/j.ajg.2020.09.007 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Arab Journal of Gastroenterology, 2021-06. Verfasst von Jong Yoon Lee und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Dong-A University College of Medicine, Busan 49201, South Korea. Hauptthemen laut MEDLINE: Anti-Ulcer Agents, Endoscopic Mucosal Resection, Stomach Neoplasms, Stomach Ulcer. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Dong-A University.
Abstract (Originalsprache)
BACKGROUND AND STUDY AIMS: Endoscopic submucosal dissection (ESD) is the most effective treatment for early gastric cancer or gastric adenoma. However, ESD results in iatrogenic ulcers and postoperative bleeding from ulcers. This study aimed to evaluate the effect of using a proton pump inhibitor (PPI) alone, a PPI + rebamipide combination therapy, and an H2 receptor antagonist (H2RA) + rebamipide combination therapy on ulcer healing after ESD. PATIENTS AND METHODS: A total of 204 patients who underwent ESD from April 2014 to July 2017 at Dong-A University Hospital were randomly assigned to the following groups: PPI-alone group, PPI + rebamipide combination therapy group, and H2RA + rebamipide combination therapy group. However, only 156 patients were studied since we excluded those who were lost to follow-up or had diseases other than early gastric cancer or gastric adenoma. Twenty-eight days after ESD, we evaluated the ulcer residual ratio, S stage rates, ulcer bleeding ratio, and gastric pH. RESULTS: This study included 156 patients (PPI-alone group: 52 patients; PPI + rebamipide group: 52 patients; H2RA + rebamipide group: 52 patients). The ulcer residual ratios were 24.3 ± 14.2%, 17.0 ± 12.1%, and 21.0 ± 13.8% in the PPI alone, PPI + rebamipide, and H2RA + rebamipide groups, respectively (P = 0.048). CONCLUSIONS: PPI + rebamipide was more effective in reducing the ulcer residual ratio after ESD. There was no statistical difference in ulcer stage and delayed bleeding after ESD among the groups. These findings showed that PPI + rebamipide had limited benefits after ESD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Dong-A University College of Medicine, Busan 49201, South Korea.
- Department of Internal Medicine, Dong-A University College of Medicine, Busan 49201, South Korea. Electronic address: jsjang@dau.ac.kr.
Förderung
- Dong-A University
Zitieren
APA
Lee, J. Y., & Jang, J. S. (2021). The effect of PPIs Alone, PPIs plus cytoprotective agent, and H2RA plus cytoprotective agent on ulcer healing after endoscopic submucosal dissection: A prospective randomized controlled trial. Arab Journal of Gastroenterology, 22(2), 115-120. https://doi.org/10.1016/j.ajg.2020.09.007
Vancouver
Lee JY, Jang JS. The effect of PPIs Alone, PPIs plus cytoprotective agent, and H2RA plus cytoprotective agent on ulcer healing after endoscopic submucosal dissection: A prospective randomized controlled trial. Arab Journal of Gastroenterology. 2021;22(2):115-120. doi:10.1016/j.ajg.2020.09.007
BibTeX
@article{Lee2021,
author = {Lee, Jong Yoon and Jang, Jin Seok},
title = {The effect of PPIs Alone, PPIs plus cytoprotective agent, and H2RA plus cytoprotective agent on ulcer healing after endoscopic submucosal dissection: A prospective randomized controlled trial},
journal = {Arab Journal of Gastroenterology},
year = {2021},
volume = {22},
number = {2},
pages = {115--120},
doi = {10.1016/j.ajg.2020.09.007}
}
EUVIMED